(NASDAQ: PTN) Palatin Technologies's forecast annual revenue growth rate of -39.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 42.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.58%.
Palatin Technologies's revenue in 2026 is $13,185,031.On average, 4 Wall Street analysts forecast PTN's revenue for 2027 to be $20,984,804, with the lowest PTN revenue forecast at $17,453,202, and the highest PTN revenue forecast at $28,049,789.
In 2028, PTN is forecast to generate $8,694,544 in revenue, with the lowest revenue forecast at $4,363,301 and the highest revenue forecast at $11,219,916.